Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities:    
Net (loss) income $ (15,876) $ 62,554
Adjustments to reconcile net (loss) income to net cash provided by operating activities:    
Change in estimated fair value of contingent liabilities (1,378) (39,377)
Depreciation and amortization of intangible assets 40,399 37,902
Amortization of premium on investments, net 75 145
Amortization of debt discount and issuance fees 639 12,863
Amortization of commercial license rights (163) 96
Loss (gain) on debt extinguishment (4,192) 7,303
Share-based compensation 31,140 28,375
Deferred income taxes (25,570) (8,229)
Loss (gain) from short-term investments 15,709 (8,135)
Lease amortization expense 4,535 3,349
Other (45) 658
Changes in operating assets and liabilities:    
Accounts receivable, net 20,550 (8,838)
Inventory 10,702 (3,103)
Accounts payable and accrued liabilities (405) (3,635)
Income tax receivable and payable 15,111 (4,167)
Deferred revenue (5,182) (20,696)
Other assets and liabilities (1,671) (5,909)
Net cash provided by operating activities 84,378 51,156
Cash flows from investing activities:    
Purchase of short-term investments (39,052) (116,898)
Proceeds from sale of short-term investments 202,552 152,465
Proceeds from maturity of short-term investments 24,830 37,100
Cash paid for equity method investment (750) 0
Purchase of property and equipment (15,792) (6,566)
Payments to CVR Holders (960) 0
Other 80 135
Net cash provided by investing activities 170,908 66,236
Cash flows from financing activities:    
Repurchase of 2023 Notes (260,949) (155,760)
Payments under financing lease obligations (42) (9,188)
Proceeds from convertible bond hedge settlement 202 18,938
Payments to convertible bond holders for warrant purchases 0 (18,446)
Net proceeds from stock option exercises and ESPP 1,831 29,484
Taxes paid related to net share settlement of equity awards (6,018) (5,903)
Payments to CVR Holders (1,545) (1,050)
Payments for OmniAb transaction costs (4,171) 0
Net cash used in financing activities (270,692) (141,925)
Net decrease in cash, cash equivalents and restricted cash (15,406) (24,533)
Cash, cash equivalents and restricted cash at beginning of period 19,522 47,963
Cash, cash equivalents and restricted cash at end of period 4,116 23,430
Supplemental disclosure of cash flow information:    
Interest paid 1,139 1,740
Taxes paid 6,630 3,720
Supplemental schedule of non-cash activity:    
Accrued fixed asset purchases 3,626 557
Accrued inventory purchases 7,676 4,968
Unrealized loss on AFS investments $ (143) $ (74)